IL301516A - Acetamido-phenyltetrazol derivatives and methods of using them - Google Patents

Acetamido-phenyltetrazol derivatives and methods of using them

Info

Publication number
IL301516A
IL301516A IL301516A IL30151623A IL301516A IL 301516 A IL301516 A IL 301516A IL 301516 A IL301516 A IL 301516A IL 30151623 A IL30151623 A IL 30151623A IL 301516 A IL301516 A IL 301516A
Authority
IL
Israel
Prior art keywords
heteroatoms selected
alkyl
membered
heterocyclyl
heteroaryl
Prior art date
Application number
IL301516A
Other languages
English (en)
Hebrew (he)
Original Assignee
Athenex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athenex Inc filed Critical Athenex Inc
Publication of IL301516A publication Critical patent/IL301516A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL301516A 2020-10-07 2021-10-07 Acetamido-phenyltetrazol derivatives and methods of using them IL301516A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063088788P 2020-10-07 2020-10-07
PCT/US2021/053937 WO2022076663A1 (en) 2020-10-07 2021-10-07 Acetamido-phenyltetrazole derivatives and methods of using the same

Publications (1)

Publication Number Publication Date
IL301516A true IL301516A (en) 2023-05-01

Family

ID=78483546

Family Applications (1)

Application Number Title Priority Date Filing Date
IL301516A IL301516A (en) 2020-10-07 2021-10-07 Acetamido-phenyltetrazol derivatives and methods of using them

Country Status (11)

Country Link
US (1) US11739089B2 (enExample)
EP (1) EP4225747A1 (enExample)
JP (2) JP7823036B2 (enExample)
KR (1) KR20230104151A (enExample)
CN (1) CN116964044B (enExample)
AU (1) AU2021358074A1 (enExample)
CA (1) CA3194694A1 (enExample)
IL (1) IL301516A (enExample)
MX (1) MX2023003933A (enExample)
TW (1) TWI900672B (enExample)
WO (1) WO2022076663A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
CN110312130B (zh) * 2019-06-25 2021-10-15 浙江大华技术股份有限公司 基于三角模式的帧间预测、视频编码方法及设备
WO2022076663A1 (en) 2020-10-07 2022-04-14 Athenex, Inc. Acetamido-phenyltetrazole derivatives and methods of using the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5663179A (en) 1992-07-10 1997-09-02 Laboratoires Glaxo Sa Certain isoquinoline derivatives having anti-tumor properties
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
GB9717576D0 (en) 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
KR100557093B1 (ko) 2003-10-07 2006-03-03 한미약품 주식회사 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법
KR101466245B1 (ko) * 2010-01-15 2014-12-01 한미사이언스 주식회사 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
KR101986683B1 (ko) * 2012-12-13 2019-06-10 한미약품 주식회사 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체
WO2015152433A1 (en) 2014-03-31 2015-10-08 Hanmi Pharm. Co., Ltd. Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
KR102293907B1 (ko) 2015-06-30 2021-08-26 한미약품 주식회사 이리노테칸 함유 경구용 고형제제 및 그 제조방법
TWI715636B (zh) 2015-09-30 2021-01-11 香港商慧源香港創新有限公司 口服紫杉烷組合物及方法
TWI833710B (zh) 2017-10-06 2024-03-01 香港商慧源香港創新有限公司 高單位含量口服型紫杉烷組合物及方法
WO2022076663A1 (en) 2020-10-07 2022-04-14 Athenex, Inc. Acetamido-phenyltetrazole derivatives and methods of using the same

Also Published As

Publication number Publication date
JP2023544615A (ja) 2023-10-24
CN116964044B (zh) 2026-03-06
KR20230104151A (ko) 2023-07-07
US11739089B2 (en) 2023-08-29
AU2021358074A1 (en) 2023-04-27
MX2023003933A (es) 2023-07-05
CN116964044A (zh) 2023-10-27
CA3194694A1 (en) 2022-04-14
US20220106312A1 (en) 2022-04-07
TWI900672B (zh) 2025-10-11
TW202233593A (zh) 2022-09-01
JP7823036B2 (ja) 2026-03-03
EP4225747A1 (en) 2023-08-16
JP2026090442A (ja) 2026-06-02
WO2022076663A1 (en) 2022-04-14

Similar Documents

Publication Publication Date Title
US20050171101A1 (en) Phenanthridinones as parp inhibitors
US7767673B2 (en) N-substituted imidazopyridine c-Kit inhibitors
TW201734001A (zh) ROR-γ調節劑
US11739089B2 (en) Acetamido-phenyltetrazole derivatives and methods of using the same
JP7106659B2 (ja) インドール-2、3-ジオキシゲナーゼ阻害剤としてのスピロ化合物
KR20220141331A (ko) P2x3 조정제
WO2024026419A1 (en) Quinoxaline derivatives as pik3 alpha modulators
AU2013276165B2 (en) Tricyclic compounds as KAT II inhibitors
WO2024026423A1 (en) Substituted quinoline derivatives as pi3k inhibitors
CN116940562B (zh) 乙酰胺基-苯基苯甲酰胺衍生物及其使用方法
CN118496203A (zh) 喹喔啉类化合物及其医药用途
HRP20010622A2 (en) Optically pure camptothecin analogues
KR20170032329A (ko) 피라졸 유도체의 제조 방법
CN118724900B (zh) 4-氨基-7-氮杂吲哚类化合物、其制备方法及应用
JP3031634B2 (ja) D1アンタゴニスト/d2アンタゴニスト及び5ht2−セロトニンアンタゴニストとしてのピペリジニル置換メタノアントラセン
HK40102895A (en) Acetamido-phenylbenzamide derivatives and methods of using the same
CN117777132A (zh) α-N-芳基氨基酰胺及其制备方法和药用用途
JP2001181281A (ja) 抗菌剤として有用なキノロン誘導体